Erschienen in:
01.08.2019 | Case report
Betamethasone
Psychomotor agitation: case report
Erschienen in:
Reactions Weekly
|
Ausgabe 1/2019
Einloggen, um Zugang zu erhalten
Excerpt
An 8-year-old boy developed psychomotor agitation during treatment with betamethasone for chronic urticaria (CU). The boy, who had CU, started receiving treatment with betamethasone 4mg daily [route not stated]. Additionally, he was receiving treatment with budesonide/formoterol [budesonide/formoterol fumarate dehydrate], cetirizine, montelukast, unspecified antihistamine and unspecified anti-leukotriene. Subsequently, his CU had temporarily regressed. However, betamethasone was discontinued due to poor tolerance and psychomotor agitation induction [duration of treatment to reaction onset and outcome not stated]. …